Original Research

DOI: 10.4244/EIJ-D-24-00116

A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study

Pablo Antúnez-Muiños1, MD, PhD; Sergio López-Tejero1, MD, PhD; Pedro Cepas-Guillén2, MD, PhD; Matias Mon-Noboa3, MD; Juan M. Ruiz-Nodar4,5, MD, PhD; Luis Andrés-Lalaguna6, MD, PhD; Fernando Rivero7, MD, PhD; Juan Gabriel Córdoba-Soriano8, MD, PhD; Ignacio J. Amat-Santos9, MD, PhD; Berenice Caneiro-Queija10, MD; David Martí Sánchez11, MD, PhD; Javier Jimeno Sánchez12, MD; Fernando Torres Mezcua4, MD; Fabián Blanco-Fernández1, MD; Jorge Sanz Sánchez7, MD, PhD; Cristina Moreno-Ambroj13, MD, PhD; Rodrigo Estévez-Loureiro10, MD, PhD; Luis Nombela-Franco3, MD, PhD; Xavier Freixa-Rofastes2, MD, PhD; Ignacio Cruz-González1, MD, PhD

Abstract

Background: Antithrombotic treatment (ATT) post-left atrial appendage occlusion (LAAO) remains controversial. Furthermore, most of the patients undergoing LAAO are at a very high bleeding risk.

Aims: This study aimed to compare a simplified versus conventional ATT after LAAO in very high bleeding risk patients.

Methods: This is a multicentre, retrospective study including very high bleeding risk patients, according to the Bleeding Academic Research Consortium (BARC) definition, who underwent LAAO. These included patients at >4% risk of BARC 3 to 5 bleeding or >1% risk of intracranial bleeding after the procedure. Two groups were established based on the discharge ATT. The simplified group included single antiplatelet treatment or no treatment, and the conventional group comprised dual antiplatelet treatment or anticoagulation (combined or not with antiplatelet therapy).

Results: A total of 1,135 patients were included. The mean CHA2DS2-VASc and HAS-BLED scores were 4.5±1.5 and 3.7±1.0, respectively. There were no differences in the composite endpoint (death, stroke, transient ischaemic attack, device-related thrombus or major bleeding) between the 2 groups (hazard ratio [HR] 0.81, 95% confidence interval [CI]: 0.59-1.11; p=0.188). Although the rate of major bleeding during the first year was numerically lower in the simplified group, it did not reach statistical significance (HR 0.67, 95% CI: 0.41-1.10; p=0.104). Nonetheless, patients with previous major bleeding presented a significantly lower rate of major bleeding when using the simplified treatment (HR 0.61, 95% CI: 0.36-0.99; p=0.049).

Conclusions: In patients with very high bleeding risk, a simplified ATT after LAAO seems to be as effective as conventional protocols. Furthermore, patients with a history of major bleeding experienced a lower risk of major bleeding with the simplified ATT.

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 16
Aug 19, 2024
Volume 20 Number 16
View full issue


Key metrics

Suggested by Cory

10.4244/EIJ-D-17-00457R Oct 20, 2017
Left atrial appendage occlusion is promising, not concerning
free

Editorial

10.4244/EIJ-E-24-00041 Aug 19, 2024
Left atrial appendage occlusion needs lifetime management not lifetime medications
Gafoor S and Panaich S
free

CLINICAL RESEARCH

10.4244/EIJ-D-17-00901 Apr 6, 2018
Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices
Weise FK et al
free

FOCUS ARTICLE

10.4244/EIJY14M09_18 Jan 22, 2015
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion
Meier B et al
free
Trending articles
167.3

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
73.55

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
60.55

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
58.3

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.9

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
25.5

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
23.55

Expert Review

10.4244/EIJ-D-23-00700 Feb 19, 2024
Evolving indications for transcatheter mitral edge-to-edge repair
Shuvy M and Maisano F
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved